Latest News

Roflumilast foam effectively eases seborrheic dermatitis


 

FROM THE EADV CONGRESS

Lesson for practice: Advise patients to moisturize?

“It seems like the vehicle would be a good skincare product for patients,” observed the session’s cochair, Jo Lambert, MD, PhD, professor and academic head of the department of dermatology at Ghent University Hospital, Belgium.

It was “a pretty dramatic vehicle response, right?” Dr. Blauvelt responded. “We normally don’t think of telling seborrheic dermatitis patients to moisturize,” he added.

“I think one of the interesting findings is perhaps we should be telling them to moisturize their scalp or moisturize their face, or it could be something unique to this particular foam.”

The study was funded by Arcutis Biotherapeutics. Dr. Blauvelt disclosed that he was an investigator for the trial and acted as consultant to the company, receiving grants/research funding and/or honoraria. Several of the study’s co-investigators are employees of Arcutis. Dr. Lambert was not involved in the study and cochaired the late-breaking session during which the STRATUM trial findings were reported.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

What’s under my toenail?
MDedge Pediatrics
Cannabinoids being studied for a variety of dermatologic conditions
MDedge Pediatrics
What is the diagnosis?
MDedge Pediatrics
Ophthalmologist who developed medical botox dies at 89
MDedge Pediatrics
An 11-year-old female presented with skin discoloration on her back
MDedge Pediatrics
A 14-year-old male presents to clinic with a new-onset rash of the hands
MDedge Pediatrics
Can dietary tweaks improve some skin diseases?
MDedge Pediatrics
FDA acts against sales of unapproved mole and skin tag products on Amazon, other sites
MDedge Pediatrics
A 9-year-old girl was evaluated for a week-long history of rash on the feet
MDedge Pediatrics
Chlorophyll water can trigger pseudoporphyria, expert warns
MDedge Pediatrics